Výsledky vyhledávání - "Amlodipine/administration & dosage"

Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension

Autor: Uwe Tegtbur, Rudi Stinkens, Thomas Langenickel, Gijs H. Goossens, Jens Jordan, Tim Heise, Marcus May, Stefan Engeli, Bas Havekes, Sven Haufe, Ellen E. Blaak, Thomas Jax, Diego Albrecht, Parasar Pal

Publikováno v: Hypertension (Dallas, Tex. : 1979)
Hypertension, 71(1), 70-77. LIPPINCOTT WILLIAMS & WILKINS

Supplemental Digital Content is available in the text.
Sacubitril/valsartan (LCZ696), a novel angiotensin receptor-neprilysin inhibitor, was recently approved for the treatment of heart failure with reduced ejection fraction. Neprilysin degrades

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf17af867ef9d1760870ae64e6058500
https://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.117.10224

Zobrazit plný text záznamu

Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure

Publikováno v: American Journal of Hypertension. 11(9):1074-1079

Double-blind, randomized controlled studies of longer than 1 week in duration comparing the antiproteinuric potential of long-acting dihydropyridine calcium channel blockers with that of angiotensin converting enzyme (ACE) inhibitors are lacking. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dris___01423::218a5ce467f5e8b8a0e0a6c359425c0b
https://research.rug.nl/en/publications/92831aec-e8a9-4f17-b038-fd1ef2e299f4

Zobrazit plný text záznamu

Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure

Publikováno v: American Journal of Hypertension. 11(9):1074-1079

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dris___00893::540b7df067b638d5d6076e9fa0b39335
https://hdl.handle.net/11370/92831aec-e8a9-4f17-b038-fd1ef2e299f4

Zobrazit plný text záznamu

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Autor: Schmieder, R. E., Kjeldsen, S. E., Julius, S., Mcinnes, G. T., Zanchetti, A., Hua, T. A., Portaluppi, Francesco

Publikováno v: Journal of hypertension. 26(3)

Atrial fibrillation (AF) is the most common arrhythmia and increases cardiovascular risk in hypertensive patients. Therefore, in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) a prespecified objective was to compare the effects of va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad8a14935c0be0759c5bc9b99c90f033
https://pubmed.ncbi.nlm.nih.gov/18300848

Zobrazit plný text záznamu

Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study

Autor: Janssen, J J, Gans, R O, van der Meulen, J, Pijpers, R, ter Wee, P M

Publikováno v: American Journal of Hypertension, 11(9), 1074-1079. Oxford Univ. Press, New York

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::70ca8ee0d58f12bdfbfab8d6403952e6
https://research.rug.nl/en/publications/92831aec-e8a9-4f17-b038-fd1ef2e299f4

Zobrazit plný text záznamu

Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia

Autor: Torsten Toftegaard Nielsen, Flemming Randsbæk, Morten Bøttcher, Jens Refsgaard, Hans Erik Bøtker, Anne Kaltoft, Mette Madsen

Publikováno v: Aarhus University
Bøttcher, M, Refsgaard, J, Madsen, M M, Randsbæk, F, Kaltoft, A, Bøtker, H E & Nielsen, T T 2003, ' Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia ', Journal of Nuclear Cardiology, vol. 10, no. 4, pp. 345-352 . https://doi.org/10.1016/s1071-3581(03)00454-9
Bøttcher, M, Refsgaard, J, Madsen, M M, Randsbæk, F, Kaltoft, A, Bøtker, H E & Nielsen, T T 2000, ' Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia ', Journal of Nuclear Cardiology, vol. 10, pp. E001-E008 .
Bøttcher, M, Refsgaard, J, Madsen, M M, Randsbæk, F, Kaltoft, A, Bøtker, H E & Nielsen, T T 2003, ' Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia ', Journal of Nuclear Cardiology, vol. 10, no. 4, pp. 345-352 . https://doi.org/10.1016/S1071-3581(03)00454-9
Bøttcher, M, Refsgaard, J, Madsen, M M, Randsbaek, F, Kaltoft, A, Bøtker, H E & Nielsen, T T 2003, ' Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia ', Journal of Nuclear Cardiology, vol. 10, no. 4, pp. 345-52 . https://doi.org/10.1016/s1071-3581(03)00454-9

BACKGROUND: Patients scheduled for myocardial perfusion imaging are often taking several antianginal drugs. There is presently no consensus concerning a regimen of discontinuation before either rest or pharmacologic stress myocardial perfusion imagin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088e5ba05c07bba18bfc49639d9bbd89
https://pure.au.dk/portal/en/publications/effect-of-antianginal-medication-on-resting-myocardial-perfusion-and-pharmacologically-induced-hyperemia(21e5681b-7688-444e-a7df-19292bc89a51).html

Zobrazit plný text záznamu

Autor: Pedro Marques da Silva, Uwe Haag, John Brazier, M. Soro, Julian F. Guest

Publikováno v: Health and Quality of Life Outcomes
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

Background\ud A post-hoc analysis was performed on the data from a 54 weeks phase III study (ClinicalTrials.gov identifier: NCT00923091) to measure changes in the health-related quality of life (HRQoL) of 2,690 patients aged ≥18 with moderate-to-se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e1d804d7429d15abcdfb93e0583de5e

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání